메뉴 건너뛰기




Volumn 151, Issue 3, 2006, Pages 755.e1-755.e6

The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

EID: 33344462287     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.12.007     Document Type: Article
Times cited : (25)

References (21)
  • 1
    • 1542347858 scopus 로고    scopus 로고
    • Actual causes of death in the United States, 2000
    • A.H. Mokdad, J.S. Marks, and D.F. Stroup Actual causes of death in the United States, 2000 JAMA 291 2004 1238 1245
    • (2004) JAMA , vol.291 , pp. 1238-1245
    • Mokdad, A.H.1    Marks, J.S.2    Stroup, D.F.3
  • 2
    • 0034945516 scopus 로고    scopus 로고
    • Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation
    • for the CHD Risk Prediction Group L.S.
    • R.B. D'Agostino, S. Grundy, L.S. Sullivan for the CHD Risk Prediction Group Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation JAMA 286 2001 180 197
    • (2001) JAMA , vol.286 , pp. 180-197
    • D'Agostino, R.B.1    Grundy, S.2    Sullivan3
  • 3
    • 0021350001 scopus 로고
    • The Lipid Research Clinics Coronary Primary Prevention Trial Results: I, reduction in the incidence of coronary heart disease
    • Lipid Research Clinics Program The Lipid Research Clinics Coronary Primary Prevention Trial Results: I, reduction in the incidence of coronary heart disease JAMA 251 1984 351 374
    • (1984) JAMA , vol.251 , pp. 351-374
    • Research Clinics Program, L.1
  • 4
    • 0021349709 scopus 로고
    • The Lipid Research Clinics Coronary Primary Prevention Trial Results: II, the relationship of reduction in incidence of coronary heart disease to cholesterol lowering
    • Lipid Research Clinics Program The Lipid Research Clinics Coronary Primary Prevention Trial Results: II, the relationship of reduction in incidence of coronary heart disease to cholesterol lowering JAMA 251 1984 365 374
    • (1984) JAMA , vol.251 , pp. 365-374
    • Research Clinics Program, L.1
  • 5
    • 0025043719 scopus 로고
    • The value of lowering cholesterol after myocardial infarction
    • J.E. Rossouw, B. Lewis, and B.M. Rifkind The value of lowering cholesterol after myocardial infarction N Engl J Med 323 1990 1112 1119
    • (1990) N Engl J Med , vol.323 , pp. 1112-1119
    • Rossouw, J.E.1    Lewis, B.2    Rifkind, B.M.3
  • 6
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2508 2509
    • (2001) JAMA , vol.285 , pp. 2508-2509
  • 7
    • 0034604225 scopus 로고    scopus 로고
    • Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study
    • Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study Circulation 102 2000 21 27
    • (2000) Circulation , vol.102 , pp. 21-27
  • 8
    • 77954070788 scopus 로고
    • Final mortality follow-up. Report of the Committee of Principal Investigators
    • WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol Final mortality follow-up. Report of the Committee of Principal Investigators Lancet 2 1984 600 604
    • (1984) Lancet , vol.2 , pp. 600-604
  • 9
    • 0023232216 scopus 로고
    • Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease
    • M.H. Frick, O. Elo, and K. Haapa Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease N Engl J Med 317 1987 1237 1245
    • (1987) N Engl J Med , vol.317 , pp. 1237-1245
    • Frick, M.H.1    Elo, O.2    Haapa, K.3
  • 10
    • 0024449985 scopus 로고
    • High-density lipoprotein-the clinical implications of recent studies
    • D.L. Gordon, and B.M. Rifkind High-density lipoprotein-the clinical implications of recent studies N Engl J Med 321 1989 1311 1316
    • (1989) N Engl J Med , vol.321 , pp. 1311-1316
    • Gordon, D.L.1    Rifkind, B.M.2
  • 11
    • 0036915240 scopus 로고    scopus 로고
    • High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease
    • A.M. Gotto High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease Am Heart J 144 Suppl 2002 33 42
    • (2002) Am Heart J , vol.144 , Issue.SUPPL. , pp. 33-42
    • Gotto, A.M.1
  • 12
    • 0034700643 scopus 로고    scopus 로고
    • High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: Assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial
    • W.E. Boden High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial Am J Cardiol 86 Suppl 2000 19L 22L
    • (2000) Am J Cardiol , vol.86 , Issue.SUPPL.
    • Boden, W.E.1
  • 13
    • 0342879940 scopus 로고    scopus 로고
    • Relation between baseline and on-treatment lipid parameters and first acute major coronary vents in the Air Force/Texas Coronary Atherosclerosis Prevention Study
    • A.M. Gotto Jr, E. Whitney, and E.A. Stein Relation between baseline and on-treatment lipid parameters and first acute major coronary vents in the Air Force/Texas Coronary Atherosclerosis Prevention Study Circulation 101 2000 477 484
    • (2000) Circulation , vol.101 , pp. 477-484
    • Gotto Jr., A.M.1    Whitney, E.2    Stein, E.A.3
  • 14
    • 0026195918 scopus 로고
    • Practice randomization and clinical research: The Indiana experience
    • W.M. Tierney, M.E. Miller, and S.L. Hui Practice randomization and clinical research: the Indiana experience Med Care 29 1991 JS57 JS64
    • (1991) Med Care , vol.29
    • Tierney, W.M.1    Miller, M.E.2    Hui, S.L.3
  • 16
    • 0033025210 scopus 로고    scopus 로고
    • The Regenstrief Medical Record System: A quarter century experience
    • C.J. McDonald, J.M. Overhage, and W.M. Tierney The Regenstrief Medical Record System: a quarter century experience Int J Med Inf 54 1999 225 253
    • (1999) Int J Med Inf , vol.54 , pp. 225-253
    • McDonald, C.J.1    Overhage, J.M.2    Tierney, W.M.3
  • 17
    • 0028895638 scopus 로고
    • Design and implementation of the Indianapolis Network for Patient Care and Research
    • J.M. Overhage, C.J. McDonald, and W.M. Tierney Design and implementation of the Indianapolis Network for Patient Care and Research MLA Bull 83 1995 48 56
    • (1995) MLA Bull , vol.83 , pp. 48-56
    • Overhage, J.M.1    McDonald, C.J.2    Tierney, W.M.3
  • 18
    • 0025921750 scopus 로고
    • Practice databases and their uses in clinical research
    • W.M. Tierney, and C.J. McDonald Practice databases and their uses in clinical research Stat Med 10 1991 541 557
    • (1991) Stat Med , vol.10 , pp. 541-557
    • Tierney, W.M.1    McDonald, C.J.2
  • 19
    • 4344665253 scopus 로고    scopus 로고
    • European Consensus Panel on HDL-C. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: The role of nicotinic acid-a position paper developed by the European Consensus Panel on HDL-C
    • M.J. Chapman, G. Assmann, and J.C. Fruchart European Consensus Panel on HDL-C. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid-a position paper developed by the European Consensus Panel on HDL-C Curr Med Res Opin 20 2004 1253 1268
    • (2004) Curr Med Res Opin , vol.20 , pp. 1253-1268
    • Chapman, M.J.1    Assmann, G.2    Fruchart, J.C.3
  • 20
    • 0035962077 scopus 로고    scopus 로고
    • Relation of gemfibrozil treatment and lipid levels with major coronary events. VA-HIT: A randomized controlled trial
    • S.J. Robins, D. Collins, and J.T. Wittes Relation of gemfibrozil treatment and lipid levels with major coronary events. VA-HIT: a randomized controlled trial JAMA 285 2001 1585 1591
    • (2001) JAMA , vol.285 , pp. 1585-1591
    • Robins, S.J.1    Collins, D.2    Wittes, J.T.3
  • 21
    • 0021353467 scopus 로고
    • Reminders to physicians from an introspective computer medical record. a two-year randomized trial.
    • C.J. McDonald, S.L. Hui, and D.M. Smith Reminders to physicians from an introspective computer medical record. A two-year randomized trial. Ann Intern Med 100 1984 130 138
    • (1984) Ann Intern Med , vol.100 , pp. 130-138
    • McDonald, C.J.1    Hui, S.L.2    Smith, D.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.